Assessment of the Scientific Literature and Historical Claims Data Regarding Exposure to Per- and Polyfluoroalkyl Substance and Kidney Cancer

The Department of Veterans Affairs VA announces that it plans to conduct an assessment of the scientific literature and historical claims data to determine whether an association between military environmental …

General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee; Notice of Meeting; Establishment of Public Docket; Request for Comments—ProSense Cryoablation System

The Food and Drug Administration FDA announces a forthcoming public advisory committee meeting of the General and Plastic Surgery Devices Panel of the Medical Devices Advisory Committee the Committee. The …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Determination of Regulatory Review Period for Purposes of Patent Extension; ORSERDU

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for ORSERDU and is publishing this

Determination of Regulatory Review Period for Purposes of Patent Extension; ORSERDU

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for ORSERDU and is publishing this

Determination of Regulatory Review Period for Purposes of Patent Extension; ORSERDU

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for ORSERDU and is publishing this

Determination of Regulatory Review Period for Purposes of Patent Extension; ORSERDU

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for ORSERDU and is publishing this

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Biosimilar Product Development Guidance; Establishment of a Public Docket; Request for Information and Comments

The Food and Drug Administration FDA or Agency is announcing the establishment of a docket to obtain information and comments that will assist the Agency in assessing how best to …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

In compliance with the

Agency Information Collection Activities; Proposals, Submissions, and Approvals

In compliance with the

Agency Information Collection Activities; Proposals, Submissions, and Approvals

In compliance with the

Agency Information Collection Activities; Proposals, Submissions, and Approvals

In compliance with the

The PACE Organization Application Process in 42 CFR Part 460 (CMS-10631)

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Determination of Regulatory Review Period for Purposes of Patent Extension; PLUVICTO

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for PLUVICTO and is publishing this notice of that determination as required

Notice of Availability of One Updated Chapter in the Environmental Protection Agency’s Air Pollution Control Cost Manual - Fabric Filters

The Environmental Protection Agency EPA is providing notice that one chapter of the current EPA Air Pollution Control Cost Manual Control Cost Manual has been updated. The EPA is requesting …

Hospital Conditions of Participation (CoPs) and Supporting Regulations (CMS-R-48)

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …

Determination of Regulatory Review Period for Purposes of Patent Extension; VANFLYTA

The Food and Drug Administration FDA or the Agency has determined the regulatory review period for VANFLYTA and is publishing this notice of that determination as required by law. FDA …

Agency Information Collection Activities; Proposals, Submissions, and Approvals

The Centers for Medicare Medicaid Services CMS is announcing an opportunity for the public to comment on CMS' intention to collect information from the public. Under the Paperwork Reduction Act …